EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Impaired fasting glucose and elevated 180-minute OGTT values predict metformin failure in gestational diabetes mellitus: a retrospective cohort study

Beeinträchtigte Nüchternglukose und erhöhter 180-Minuten-OGTT-Wert sagen Metformin-Versagen bei Gestationsdiabetes voraus: retrospektive Kohortenstudie

Sivan Farladansky-Gershnabel, May Weinberg, Reut Baram, Shani Saffer, Ilil Mishani-Sagi, Or Eliner, Tal Biron-Shental, Dorit Ravid

Archives of Gynecology and Obstetrics · 21.07.2026 · 313 (1)

DOI: 10.1007/s00404-026-08528-7 ↗

Auf einen Blick

Bei Frauen mit Gestationsdiabetes unter Metformin waren eine beeinträchtigte Nüchternglukose und ein erhöhter 180-Minuten-OGTT-Wert mit Metformin-Versagen verbunden. 114 von 425 Frauen benötigten zusätzlich Insulin.

Fragestellung

Sagen OGTT-basierte Stoffwechselstörungen und maternale Merkmale ein Metformin-Versagen bei Gestationsdiabetes voraus?

Methode

Retrospektive Kohortenstudie an einem tertiären Zentrum mit Frauen mit Einlingsschwangerschaft und Gestationsdiabetes unter Metformin (2018–2023). Primärer Endpunkt war Metformin-Versagen als spätere Insulintherapie.

Ergebnisse

Von 425 Frauen benötigten 114 (26,8 %) Insulin. IFG war mit Metformin-Versagen assoziiert (aOR 1,96; 95 %-KI 1,25–3,07), ebenso ein abnormaler 180-Minuten-OGTT-Wert (aOR 4,92; 95 %-KI 2,50–9,66).

Schlussfolgerung der Autor:innen

IFG und ein erhöhter 180-Minuten-OGTT-Wert können Frauen mit GDM mit höherem Risiko für eine Therapieeskalation identifizieren.

Kernaussagen

  • 114 von 425 Frauen benötigten zusätzlich Insulin
  • IFG: aOR 1,96 (95 %-KI 1,25–3,07)
  • Abnormaler 180-Minuten-Wert: aOR 4,92 (95 %-KI 2,50–9,66)

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Kohortenstudie in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 21.07.2026. Verfasst von Sivan Farladansky-Gershnabel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel. sivangershnabel@gmail.com. Hauptthemen laut MEDLINE: Diabetes, Gestational, Metformin, Hypoglycemic Agents, Blood Glucose. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate whether oral glucose tolerance test (OGTT)-derived metabolic abnormalities and maternal characteristics predict metformin failure in women with gestational diabetes mellitus (GDM).

Methods

This retrospective cohort study included women with singleton pregnancies and gestational diabetes mellitus treated with metformin at a tertiary center (2018–2023). Gestational diabetes mellitus was diagnosed using the American Diabetes Association (ADA) two-step approach, consisting of an initial 50-g glucose challenge screening test followed, when abnormal, by a diagnostic 100-g, 3-h oral glucose tolerance test performed under fasting conditions and interpreted according to Carpenter-Coustan criteria (fasting ≥ 95 mg/dL, 1-h ≥ 180 mg/dL, 2-h ≥ 155 mg/dL, and 3-h ≥ 140 mg/dL). Routine screening was generally performed between 24 and 28 weeks’ gestation, with earlier testing in high-risk women when clinically indicated. Of 431 women who initiated metformin, 6 discontinued due to adverse effects, leaving 425 for analysis. Impaired fasting glucose (IFG) was defined as fasting OGTT ≥ 95 mg/dL. The primary outcome was metformin failure, defined as subsequent insulin initiation. Multivariable logistic regression included prespecified OGTT-derived phenotypes rather than simultaneous inclusion of all continuous OGTT variables in order to reduce multicollinearity.

Results

Among 425 women, 114 (26.8%) required insulin. These women had higher glucose values at all OGTT time points and a higher prevalence of IFG (41.2% vs 26.4%, p = 0.005). An abnormal 180-min value was also more frequent (21.1% vs 5.1%, p < 0.001). The number of abnormal OGTT values did not differ significantly between groups and was not independently associated with metformin failure. In multivariable analysis, IFG (aOR 1.96, 95% CI 1.25–3.07) and an abnormal 180-min OGTT value (aOR 4.92, 95% CI 2.50–9.66) remained independently associated with metformin failure.

Conclusion

IFG and an elevated 180-min OGTT value may identify women with GDM at higher risk for treatment escalation. These findings should not be interpreted as direct indications for insulin initiation but rather as potential markers of increased risk for metformin failure requiring closer glycemic surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalMetforminHypoglycemic AgentsBlood GlucoseHumansFemalePregnancyRetrospective StudiesGlucose Tolerance TestAdultFastingTreatment FailureInsulin

Stichwörter der Autor:innen

Gestational diabetes mellitusImpaired fasting glucoseInsulin therapyMetabolic phenotypeMetforminOral glucose tolerance test

Substanzen

MetforminHypoglycemic AgentsBlood GlucoseInsulin

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel. sivangershnabel@gmail.com.
  • Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel. sivangershnabel@gmail.com.
  • Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
  • Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.

Förderung

  • Tel Aviv University

Zitieren

APA

Farladansky-Gershnabel, S., Weinberg, M., Baram, R., Saffer, S., Mishani-Sagi, I., Eliner, O., Biron-Shental, T., & Ravid, D. (2026). Impaired fasting glucose and elevated 180-minute OGTT values predict metformin failure in gestational diabetes mellitus: a retrospective cohort study. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-026-08528-7

Vancouver

Farladansky-Gershnabel S, Weinberg M, Baram R, Saffer S, Mishani-Sagi I, Eliner O, et al. Impaired fasting glucose and elevated 180-minute OGTT values predict metformin failure in gestational diabetes mellitus: a retrospective cohort study. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-026-08528-7

BibTeX
@article{FarladanskyGershnabel2026,
  author = {Farladansky-Gershnabel, Sivan and Weinberg, May and Baram, Reut and Saffer, Shani and Mishani-Sagi, Ilil and Eliner, Or and Biron-Shental, Tal and Ravid, Dorit},
  title = {Impaired fasting glucose and elevated 180-minute OGTT values predict metformin failure in gestational diabetes mellitus: a retrospective cohort study},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2026},
  volume = {313},
  number = {1},
  doi = {10.1007/s00404-026-08528-7}
}
Kostenlos starten →